Supriti Mulay

Anjany Sekuboyina, Malek E. Husseini, Amirhossein Bayat et al.

Vertebral labelling and segmentation are two fundamental tasks in an automated spine processing pipeline. Reliable and accurate processing of spine images is expected to benefit clinical decision-support systems for diagnosis, surgery planning, and population-based analysis on spine and bone health. However, designing automated algorithms for spine processing is challenging predominantly due to considerable variations in anatomy and acquisition protocols and due to a severe shortage of publicly available data. Addressing these limitations, the Large Scale Vertebrae Segmentation Challenge (VerSe) was organised in conjunction with the International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI) in 2019 and 2020, with a call for algorithms towards labelling and segmentation of vertebrae. Two datasets containing a total of 374 multi-detector CT scans from 355 patients were prepared and 4505 vertebrae have individually been annotated at voxel-level by a human-machine hybrid algorithm (https://osf.io/nqjyw/, https://osf.io/t98fz/). A total of 25 algorithms were benchmarked on these datasets. In this work, we present the the results of this evaluation and further investigate the performance-variation at vertebra-level, scan-level, and at different fields-of-view. We also evaluate the generalisability of the approaches to an implicit domain shift in data by evaluating the top performing algorithms of one challenge iteration on data from the other iteration. The principal takeaway from VerSe: the performance of an algorithm in labelling and segmenting a spine scan hinges on its ability to correctly identify vertebrae in cases of rare anatomical variations. The content and code concerning VerSe can be accessed at: https://github.com/anjany/verse.

Krishan Agyakari Raja Babu, Supriti Mulay, Om Prabhu et al.

Deep generative models and synthetic medical data have shown significant promise in addressing key challenges in healthcare, such as privacy concerns, data bias, and the scarcity of realistic datasets. While research in this area has grown rapidly and demonstrated substantial theoretical potential, its practical adoption in clinical settings remains limited. Despite the benefits synthetic data offers, questions surrounding its reliability and credibility persist, leading to a lack of trust among clinicians. This position paper argues that fostering trust in synthetic medical data is crucial for its clinical adoption. It aims to spark a discussion on the viability of synthetic medical data in clinical practice, particularly in the context of current advancements in AI. We present empirical evidence from brain tumor segmentation to demonstrate that the quality, diversity, and proportion of synthetic data directly impact trust in clinical AI models. Our findings provide insights to improve the deployment and acceptance of synthetic data-driven AI systems in real-world clinical workflows.